Document is current
Any future updates will be listed below
-
Authors
Robinson, Rachel L.
Gardeitchik, Thatjana
Schouten, Meyke I.
Jungbluth, Heinz https://orcid.org/0000-0002-7159-3427
Voermans, Nicol C.
Stowell, Kathryn https://orcid.org/0000-0002-5574-7211
Hopkins, Phil M. https://orcid.org/0000-0002-8127-1739
Girard, Thierry
Gutowska-Ding, Weronika
Sheils, Katie https://orcid.org/0000-0002-1649-1495
Kamsteeg, Erik-Jan https://orcid.org/0000-0001-6480-1892
- License Information
-
More Information
Article History
Received: 28 November 2025
Revised: 20 March 2026
Accepted: 16 April 2026
First Online: 12 May 2026
Competing interests
: HJ has acted in an advisory capacity for the RYR1 Foundation (Pittsburgh, PA, USA), and for ARMGO, a pharmaceutical company developing therapies for RYR1-related disorders.
